RIBOPRO, established in 2020, is a burgeoning player in the Biotechnology and Health Care sectors, headquartered in The Netherlands. Embracing the slogan "Dream ahead.," the company specializes in developing high-quality, high-performance RNA products that cater to the growing demand for advanced research tools and therapeutics.
Its unique value proposition lies in offering a blend of both off-the-shelf and customizable RNA solutions at competitive pricing and expedited delivery. This agile approach significantly alleviates the operational hurdles faced by researchers and developers, enabling them to focus more on innovation and application.
Recently, RIBOPRO secured a €1.90M Convertible Note investment from notable investors such as Vlasroot Group, BOM - Brabant Regional Development Agency, and Fredriks Family Office as of 01 January 2024. This funding infused fresh capital into the venture, reinforcing its market position and fueling further growth in the biotechnology landscape.